Q4 2023 · CIK 1581811 Snapshot · — Export CSV
Manager file · EC · Egerton Capital (UK) LLP

John Armitage - Egerton Capital

EDGAR CIK 1581811 ↗ · Filed · typical filing lag 43 days · Egerton Capital (UK) LLP is the current filer; Egerton Capital Ltd (1083657) last 13F 2013

Export CSV
Reported portfolio value
$9.23B
QoQ reported +7.1% · vs Q3 2023
Positions
22
2 new · 2 exited
Top 10 concentration
69.8%
largest position 10.3%
Position churn · Q4 2023
11 added · 9 trimmed
new positions 5.5% · exits 0.0% of book
Holdings · Q4 2023 · 22
Security Weight Δ wt Price* Shares Δ shares Value Action
1 V VISA INC 10.35% +1.4% $260 3.67M +9.7% $955M Added
2 CP CANADIAN PACIFIC KANSAS CITY 9.76% -4.5% $79 11.40M -31.0% $901M Trimmed
3 AMZN AMAZON COM INC 7.65% +6.9% $152 4.65M +826.3% $706M Added
4 CNI CANADIAN NATL RY CO 7.22% +0.7% $126 5.31M +2.7% $667M Added
5 MSFT MICROSOFT CORP 7.01% +2.2% $376 1.72M +32.3% $647M Added
6 META META PLATFORMS INC 6.91% -1.0% $354 1.80M -20.5% $637M Trimmed
7 GE GENERAL ELECTRIC CO 5.95% +1.0% $128 4.30M +12.2% $549M Added
8 GOOG ALPHABET INC 5.29% -1.7% $141 3.46M -24.3% $488M Trimmed
9 FISV FISERV INC 4.96% +0.3% $133 3.45M -2.6% $458M Trimmed
10 FCNCA FIRST CTZNS BANCSHARES INC N 4.66% -0.8% $1.42K 303K -10.8% $430M Trimmed
11 BKNG BOOKING HOLDINGS INC 4.14% -0.2% $3.55K 108K -12.1% $382M Trimmed
12 — RENAISSANCERE HLDGS LTD 3.49% +0.3% $196 1.64M +16.7% $322M Added
13 IBN ICICI BANK LIMITED 3.18% +0.9% $24 12.32M +44.2% $294M Added
14 GEHC GE HEALTHCARE TECHNOLOGIES I 2.93% +2.9% $77 3.50M new $270M New
15 HLT HILTON WORLDWIDE HLDGS INC 2.57% +1.5% $182 1.30M +103.5% $237M Added
16 — CENOVUS ENERGY INC 2.56% -2.8% $17 14.19M -36.6% $236M Trimmed
17 — CRH PLC 2.54% +2.5% $69 3.39M new $235M New
18 MA MASTERCARD INCORPORATED 2.49% -3.3% $427 538K -57.5% $229M Trimmed
19 HDB HDFC BANK LTD 2.05% +0.1% $67 2.82M +0.4% $190M Added
20 SLB SCHLUMBERGER LTD 1.86% -4.8% $52 3.30M -66.5% $171M Trimmed
21 — ARCH CAP GROUP LTD 1.61% +0.2% $74 2.00M +33.3% $148M Added
22 SHEL SHELL PLC 0.84% +0.1% $66 1.17M +20.6% $77.20M Added
23 KKR KKR & CO INC 0.00% -1.0% — 0 1.39M → 0 $0 Exited
24 — EVEREST GROUP LTD 0.00% -1.0% — 0 223K → 0 $0 Exited

* Price = reported value ÷ shares at quarter end (13F does not disclose cost basis). Δ wt = this position's share of the reported portfolio versus the prior quarter. Options are shown separately when filed.

This quarter's moves
  • GE HEALTHCARE TECHNOLOGIES I 2.93% · $270M
  • CRH PLC 2.54% · $235M
  • KKR & CO INC was 1.00% · 1.39M sh
  • EVEREST GROUP LTD was 0.96% · 223K sh
  • Filing detail
    Period2023-12-31
    Accepted12 Feb 2024 · 11:02 ET
    Filing lag43 days
    Form13F-HR
    Information rows22
    Quarters on file13
    Portfolio value
    Q3 2023Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026$10.35B Q3 2023Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 202630
    Quarterly history · 13 filings
    QuarterPeriod endReported valuePositionsLargestNewExitedFiledLag
    Q3 2026 2026-09-30 $9.82B 23 14.9% 4 4 20 Oct 2026 ET 20
    Q2 2026 2026-06-30 $10.35B 23 14.1% 5 6 21 Jul 2026 ET 21
    Q1 2026 2026-03-31 $9.01B 24 13.8% 7 6 13 May 2026 ET 43
    Q4 2025 2025-12-31 $9.20B 23 14.8% 8 9 11 Feb 2026 ET 42
    Q3 2025 2025-09-30 $9.48B 24 9.9% 3 4 12 Nov 2025 ET 43
    Q2 2025 2025-06-30 $9.75B 25 9.4% 4 6 12 Aug 2025 ET 43
    Q1 2025 2025-03-31 $8.67B 27 9.3% 2 5 06 May 2025 ET 36
    Q4 2024 2024-12-31 $8.65B 30 8.6% 8 8 10 Feb 2025 ET 41
    Q3 2024 2024-09-30 $9.91B 30 7.5% 6 2 05 Nov 2024 ET 36
    Q2 2024 2024-06-30 $9.90B 26 7.6% 6 2 13 Aug 2024 ET 44
    Q1 2024 2024-03-31 $10.35B 22 8.7% 3 3 13 May 2024 ET 43
    Q4 2023 2023-12-31 $9.23B 22 10.3% 2 2 12 Feb 2024 ET 43
    Q3 2023 2023-09-30 $8.62B 22 14.3% — — 13 Nov 2023 ET 44
    Track record · return since filing
    Paper return of each reported book
    Since Q3 2023
    +62.3%
    S&P 500 +74.9%
    Hit rate · latest book
    57%
    priced positions with positive return
    Priced coverage
    95%
    of reported stock value
    Q3 2023Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026Reported bookS&P 500
    Quarter by quarter
    QuarterBookS&P 500ExcessCoverageBest call
    Q3 2026 -2.1% -3.5% +1.4% 95% V +5.7%
    Q2 2026 -1.2% -0.6% -0.7% 94% V +21.0%
    Q1 2026 +1.2% +0.5% +0.7% 89% V +34.4%
    Q4 2025 +8.3% +8.1% +0.1% 93% AMZN +26.7%
    Q3 2025 +4.9% +9.8% -4.9% 84% V +27.6%
    Q2 2025 +9.5% +17.1% -7.6% 84% V +28.7%
    Q1 2025 +21.8% +35.0% -13.3% 85% LLY +88.8%
    Q4 2024 +12.4% +25.1% -12.8% 82% GE +61.1%
    Q3 2024 +25.4% +31.7% -6.3% 82% IBKR +105.0%
    Q2 2024 +40.9% +40.5% +0.3% 85% IBKR +170.6%
    Q1 2024 +36.0% +46.7% -10.7% 87% GE +108.3%
    Q4 2023 +43.3% +53.0% -9.7% 90% GE +197.6%
    Q3 2023 +62.3% +74.9% -12.6% 89% GE +261.3%
    Copy-trade simulation
    Hypothetical strategy
    +49.4%
    13 rebalances
    S&P 500 same window
    +74.9%
    excess -25.4%

    Simulation: at each filing date, buy the manager's ten largest reported common-stock positions in equal weight; hold until the next filing. Prices are split- and dividend-adjusted closes. It ignores the 45-day disclosure lag's cost to a real copycat beyond the filing-date entry, taxes, fees and liquidity. It is a reading aid, not a backtest of the manager's fund.